NAD+ Supplements, Global Market Size Forecast, Top 13 Players Rank and Market Share-heyan(1) | |
NAD+ (Nicotinamide Adenine Dinucleotide) supplements are oral or intravenous formulations designed to increase levels of NAD+ in the body. NAD+ is a coenzyme found in all living cells, playing a critical role in various biological processes, particularly in energy metabolism and cellular functions. According to the new market research report "Global NAD+ Supplements Market Report 2023-2029", published by QYResearch, the global NAD+ Supplements market size is projected to grow from USD 447 million in 2023 to USD 10.43 billion by 2029, at a CAGR of 15.2% during the forecast period. This report profiles key players of NAD+ Supplements such as EffePharm, Herbalmax, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Chromadex, GeneHarbor In 2022, the global top five NAD+ Supplements players account for 60% of market share in terms of revenue. Above figure shows the key players ranked by revenue in NAD+ Supplements. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com | |
Target Prov.: All Provinces Target City : All Cities Last Update : Apr 02, 2024 4:09 AM Number of Views: 54 | Item Owner : Laura Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |